RCD SystemsBiotechnecalcinosisActivin Asystemic sclerosis (SSc)CD206 antagonistSSc
…CD206 antagonist(10 µM) and an Activin A neutralising antibody (RCD Systems, 10 µg/mL) was used to assess therapeutic potential. Complement…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…CD206 antagonist(10 µM) and an Activin A neutralising antibody (RCD Systems, 10 µg/mL) was used to assess therapeutic potential. Complement…